Market News / Story
VALN Stock Plunges 7% After-Hours As UK Revokes Valneva’s IXCHIQ Authorization In Latest Market Setback
Stocktwits ·
Stocktwits reports: Valneva shares fell as much as 7% in after-hours trading on Wednesday after the company said U.K. regulators had revoked the marketing authorization for its chikungunya vaccine, IXCHIQ, marking another setback for a product that has already lost its U.S. license. UK License Pulled Valneva said the Medicines and Healthcare products Regulatory Agency withdrew the U.K. authorization after a further review by the Commission on Human Medicines. The agency looked again at…